Skip to main content

03.01.2024 | Original articles

The predictive value of PRECISE-DAPT score for long-term mortality in patients with acute coronary syndrome complicated by cardiogenic shock

verfasst von: Prof. Sukru Akyuz, MD, Assoc. Prof. Ali Nazmi Calik, MD, Assoc. Prof. Tolga Onuk, MD, Assoc. Prof. Baris Yaylak, MD, Zeynep Kolak, MD, Semih Eren, MD, Feyza Mollaalioglu, MD, Furkan Durak, MD, Prof. Mustafa Cetin, MD, Prof./Assoc. Prof. Ibrahim Halil Tanboga, MD, PhD

Erschienen in: Herz

Einloggen, um Zugang zu erhalten

Abstract

Background

Besides its primary clinical utility in predicting bleeding risk in patients with acute coronary syndrome (ACS), the PRECISE-DAPT (Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Anti-Platelet Therapy) score may also be useful for predicting long-term mortality in ACS patients presenting with cardiogenic shock (CS) since several studies have reported an association between the score and certain cardiovascular conditions or events. The aim of the present study was to evaluate the utility of the PRECISE-DAPT score for predicting the long-term all-cause mortality in patients (n = 293) with ACS presenting with CS.

Methods

The PRECISE-DAPT score was calculated for each patient who survived in hospital, and the association with long-term mortality was studied. Median follow-up time was 2.7 years. The performance of the final model was determined with measurements of its discriminative power (Harrell’s and Uno’s C indices and time-dependent area under the receiver operating characteristic curve [AUC]) and predictive accuracy (coefficient of determination [R2] and likelihood ratio χ2). Hazard ratios (HRs) were used to assess the relationship between the variables of the model and long-term all-cause death.

Results

All-cause death occurred in 197 patients (67%). There was a positive association between the PRECISE-DAPT score (change from 17 to 38 was associated with an HR of 2.42 [95% CI: 1.59–3.68], R2 = 0.209, time-dependent AUC = 0.69) and the risk of death such that in the adjusted survival curve, the risk of mortality increased as the PRECISE-DAPT score increased.

Conclusion

The PRECISE-DAPT score may be a useful easy-to-use tool for predicting long-term mortality in patients with ACS complicated by CS.
Literatur
1.
Zurück zum Zitat Costa F, van Klaveren D, James S et al (2017) PRECISE-DAPT Study Investigators. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual patient datasets from clinical trials. Lancet 389:1025–1034CrossRefPubMed Costa F, van Klaveren D, James S et al (2017) PRECISE-DAPT Study Investigators. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual patient datasets from clinical trials. Lancet 389:1025–1034CrossRefPubMed
2.
Zurück zum Zitat Tanik VO, Cinar T, Arugaslan E et al (2019) The predictive value of PRECISE-DAPT score for in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology 70:440–447CrossRefPubMed Tanik VO, Cinar T, Arugaslan E et al (2019) The predictive value of PRECISE-DAPT score for in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology 70:440–447CrossRefPubMed
3.
Zurück zum Zitat Ando T, Nakazato K, Kimishima Y et al (2020) The clinical value of the PRECISE-DAPT score in predicting long-term prognosis in patients with acute myocardial infarction. Int J Cardiol Heart Vasc 29:100552PubMedPubMedCentral Ando T, Nakazato K, Kimishima Y et al (2020) The clinical value of the PRECISE-DAPT score in predicting long-term prognosis in patients with acute myocardial infarction. Int J Cardiol Heart Vasc 29:100552PubMedPubMedCentral
4.
Zurück zum Zitat Long T, Peng L, Li F et al (2018) Correlations of DAPT score and PRECISE-DAPT score with the extent of coronary stenosis in acute coronary syndrome. Medicine 97:e12531CrossRefPubMedPubMedCentral Long T, Peng L, Li F et al (2018) Correlations of DAPT score and PRECISE-DAPT score with the extent of coronary stenosis in acute coronary syndrome. Medicine 97:e12531CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Cinar T, Tanik VO, Arugaslan E et al (2019) The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiovasc Interv Ther 34:207–215CrossRefPubMed Cinar T, Tanik VO, Arugaslan E et al (2019) The association of PRECISE-DAPT score with development of contrast-induced nephropathy in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiovasc Interv Ther 34:207–215CrossRefPubMed
6.
Zurück zum Zitat Yildirim E, Turkkan C, Ozcan KS et al (2019) The predictive value of PRECISE-DAPT score for arrhythmic complications in patients with ST-elevation myocardial infarction. Coron Artery Dis 30:499–504CrossRefPubMed Yildirim E, Turkkan C, Ozcan KS et al (2019) The predictive value of PRECISE-DAPT score for arrhythmic complications in patients with ST-elevation myocardial infarction. Coron Artery Dis 30:499–504CrossRefPubMed
7.
Zurück zum Zitat Selcuk M, Cinar T, Saylık F et al (2022) The association of a PRECISE-DAPT score with no-reflow in patients with ST-segment elevation myocardial infarction. Angiology 73(1):68–72CrossRefPubMed Selcuk M, Cinar T, Saylık F et al (2022) The association of a PRECISE-DAPT score with no-reflow in patients with ST-segment elevation myocardial infarction. Angiology 73(1):68–72CrossRefPubMed
8.
Zurück zum Zitat Demir M, Korkmaz A, Demirtas B (2021) The predictive value of PRECISE-DAPT score for mortality in patients with acute decompansed heart failure. Int J Cardiovasc Acad 7:70–77CrossRef Demir M, Korkmaz A, Demirtas B (2021) The predictive value of PRECISE-DAPT score for mortality in patients with acute decompansed heart failure. Int J Cardiovasc Acad 7:70–77CrossRef
9.
Zurück zum Zitat Erken Pamukcu H, Tanik VO et al (2021) The association between the PRECISE-DAPT score and new-onset atrial fibrillation in patients with ST-elevation myocardial infarction. J Teh Univ Heart Ctr 16(1):20–25 Erken Pamukcu H, Tanik VO et al (2021) The association between the PRECISE-DAPT score and new-onset atrial fibrillation in patients with ST-elevation myocardial infarction. J Teh Univ Heart Ctr 16(1):20–25
10.
Zurück zum Zitat Collet JP, Thiele H, Barbato E et al (2021) ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42(14):1289–1367CrossRefPubMed Collet JP, Thiele H, Barbato E et al (2021) ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42(14):1289–1367CrossRefPubMed
11.
Zurück zum Zitat Ibanez B, James S, Agewall S et al (2018) ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177CrossRefPubMed Ibanez B, James S, Agewall S et al (2018) ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177CrossRefPubMed
12.
Zurück zum Zitat Jeger RV, Radovanovic D, Hunziker PR et al (2008) Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med 149:618–626CrossRefPubMed Jeger RV, Radovanovic D, Hunziker PR et al (2008) Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med 149:618–626CrossRefPubMed
13.
Zurück zum Zitat Conde-Vela C, Moreno R, Hernandez R et al (2007) Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: related factors. Int J Cardiol 123:29–33CrossRefPubMed Conde-Vela C, Moreno R, Hernandez R et al (2007) Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: related factors. Int J Cardiol 123:29–33CrossRefPubMed
14.
Zurück zum Zitat Supeł K, Kacprzak M, Zielińska M (2020) Shock index and TIMI risk index as valuable prognostic tools in patients with acute coronary syndrome complicated by cardiogenic shock. PLoS ONE 15(1):e227374CrossRefPubMedPubMedCentral Supeł K, Kacprzak M, Zielińska M (2020) Shock index and TIMI risk index as valuable prognostic tools in patients with acute coronary syndrome complicated by cardiogenic shock. PLoS ONE 15(1):e227374CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Choi SY, Kim MH, Cho YR et al (2018) Performance of PRECISE-DAPT score for predicting bleeding complication during dual antiplatelet therapy. Circ Cardiovasc Interv 11:e6837CrossRefPubMed Choi SY, Kim MH, Cho YR et al (2018) Performance of PRECISE-DAPT score for predicting bleeding complication during dual antiplatelet therapy. Circ Cardiovasc Interv 11:e6837CrossRefPubMed
16.
Zurück zum Zitat Thiele H, Zeymer U, Neumann FJ et al (2012) IABPSHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296CrossRefPubMed Thiele H, Zeymer U, Neumann FJ et al (2012) IABPSHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287–1296CrossRefPubMed
Metadaten
Titel
The predictive value of PRECISE-DAPT score for long-term mortality in patients with acute coronary syndrome complicated by cardiogenic shock
verfasst von
Prof. Sukru Akyuz, MD
Assoc. Prof. Ali Nazmi Calik, MD
Assoc. Prof. Tolga Onuk, MD
Assoc. Prof. Baris Yaylak, MD
Zeynep Kolak, MD
Semih Eren, MD
Feyza Mollaalioglu, MD
Furkan Durak, MD
Prof. Mustafa Cetin, MD
Prof./Assoc. Prof. Ibrahim Halil Tanboga, MD, PhD
Publikationsdatum
03.01.2024
Verlag
Springer Medizin
Erschienen in
Herz
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-023-05231-0

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.